351 related articles for article (PubMed ID: 17130506)
1. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy.
Fox TE; Han X; Kelly S; Merrill AH; Martin RE; Anderson RE; Gardner TW; Kester M
Diabetes; 2006 Dec; 55(12):3573-80. PubMed ID: 17130506
[TBL] [Abstract][Full Text] [Related]
2. Diabetes diminishes phosphatidic acid in the retina: a putative mediator for reduced mTOR signaling and increased neuronal cell death.
Fox TE; Young MM; Pedersen MM; Han X; Gardner TW; Kester M
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7257-67. PubMed ID: 22952117
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
[TBL] [Abstract][Full Text] [Related]
5. Glucose availability and glycolytic metabolism dictate glycosphingolipid levels.
Stathem M; Marimuthu S; O'Neal J; Rathmell JC; Chesney JA; Beverly LJ; Siskind LJ
J Cell Biochem; 2015 Jan; 116(1):67-80. PubMed ID: 25145677
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Ceramide Effects on the Retinal Pigment Epithelium in Diabetes.
Levitsky Y; Hammer SS; Fisher KP; Huang C; Gentles TL; Pegouske DJ; Xi C; Lydic TA; Busik JV; Proshlyakov DA
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481596
[TBL] [Abstract][Full Text] [Related]
7. Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.
Chakravarthy H; Navitskaya S; O'Reilly S; Gallimore J; Mize H; Beli E; Wang Q; Kady N; Huang C; Blanchard GJ; Grant MB; Busik JV
Stem Cells; 2016 Apr; 34(4):972-83. PubMed ID: 26676316
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3: a key kinase in retinal neuron apoptosis in early diabetic retinopathy.
Li Z; Ma L; Chen X; Li Y; Li S; Zhang J; Lu L
Chin Med J (Engl); 2014; 127(19):3464-70. PubMed ID: 25269915
[TBL] [Abstract][Full Text] [Related]
11. A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.
Zador IZ; Deshmukh GD; Kunkel R; Johnson K; Radin NS; Shayman JA
J Clin Invest; 1993 Mar; 91(3):797-803. PubMed ID: 8450061
[TBL] [Abstract][Full Text] [Related]
12. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats.
Kumar B; Gupta SK; Nag TC; Srivastava S; Saxena R; Jha KA; Srinivasan BP
Exp Eye Res; 2014 Aug; 125():193-202. PubMed ID: 24952278
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.
Hatcher HC; Ma JX; Chao J; Chao L; Ottlecz A
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):658-64. PubMed ID: 9071220
[TBL] [Abstract][Full Text] [Related]
14. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
15. Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
Obanda DN; Yu Y; Wang ZQ; Cefalu WT
J Nutr Biochem; 2015 Jul; 26(7):687-95. PubMed ID: 25771159
[TBL] [Abstract][Full Text] [Related]
16. SIK2 is involved in the negative modulation of insulin-dependent muller cell survival and implicated in hyperglycemia-induced cell death.
Küser-Abali G; Ozcan F; Ugurlu A; Uysal A; Fuss SH; Bugra-Bilge K
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3526-37. PubMed ID: 23599336
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the impact of diabetes on retinal metabolites by NMR spectroscopy.
Santiago AR; Garrido MJ; Cristóvão AJ; Duarte JM; Carvalho RA; Ambrósio AF
Curr Eye Res; 2010 Nov; 35(11):992-1001. PubMed ID: 20958188
[TBL] [Abstract][Full Text] [Related]
18. Inverse relationship between the intraretinal concentration of bioavailable nitric oxide and blood glucose in early experimental diabetic retinopathy.
Guthrie MJ; Osswald CR; Kang-Mieler JJ
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):37-44. PubMed ID: 25503458
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina.
Park SH; Park JW; Park SJ; Kim KY; Chung JW; Chun MH; Oh SJ
Diabetologia; 2003 Sep; 46(9):1260-8. PubMed ID: 12898017
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of phosphorylated c-Jun and phosphorylated c-Jun N-terminal kinase associated with neuronal cell death in diabetic and high glucose exposed rat retinas.
Oshitari T; Bikbova G; Yamamoto S
Brain Res Bull; 2014 Feb; 101():18-25. PubMed ID: 24333191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
